Filter By:
- Year
-
Scheme
AIIHPC Structured Research Network Applied Partnership Awards Applied Research Projects in Dementia Cancer Prevention Fellowship Programme Cochrane Training Fellowships Collaborative Doctoral Awards Convenor of Cochrane Ireland Award Definitive Intervention and Feasibility Awards Emerging Investigator Awards Framework for Safe Nurse Staffing and Skill Mix Health Research Awards Health Research Awards - Definitive Interventions Health Research Centres HRB Clinical Research Coordination Ireland HRB Clinical Research Facilities HRB Clinical Trials Networks HRB Collaboration in Ireland for Clinical Effectiveness Reviews HRB Trials Methodology Research Network ICORG Statistics and Data Management Interdisciplinary Capacity Enhancement Awards Investigator Led Projects Irish Clinical Oncology Research Group Irish Network for Research in Dementia and Neurodegeneration Irish Platform for Patients Organisations Science and Industry Support Award Joint Programming Initiative Healthy Diet for a Healthy Life Joint Programming Initiative in Neurodegenerative Diseases Joint Programming Initiative on Antimicrobial Resistance Knowledge Exchange and Dissemination Scheme Medical Education Research Grants Medical Research Charities Group Support Award MRCG-HRB Joint Funding Scheme National Children's Hospital Foundation Scheme National Intellectual Disability Supplement to TILDA National SpR/SR Academic Fellowship Programme PPI Ignite Awards Project Development Grants Research Collaborative in Quality and Patient Safety Research Leader Awards Research Training Fellowships for Health Professionals Research Training Fellowships for Healthcare Professionals SFI-HRB-Wellcome Research Partnership Structured PhD Programme in Population and Health-Services Research Education The Irish Longitudinal Study on Ageing Ulysses Research Visits US-Ireland R&D Partnership Awards
-
Host Institution
Alpha One Foundation Athlone Institute of Technology Beaumont Hospital Cystinosis Foundation Ireland Department of Agriculture, Food and Marine Dublin City University Dublin Dental University Hospital Dublin Institute of Technology Economic and Social Research Institute Fighting Blindness Health Information and Quality Authority HSE - Letterkenny General Hospital HSE - Midland Regional Hospital at Tullamore Irish Cancer Society Irish Clinical Oncology Research Group Ltd Irish Platform for Patients Organisations Science and Industry Irish Thoracic Society Katholieke Universiteit Leuven Mary Immaculate College Limerick Maynooth University Medical Research Charities Group Ltd Molecular Medicine Ireland National Rehabilitation Hospital National Suicide Research Foundation National University of Ireland, Galway National University of Ireland, Maynooth Our Lady's Hospice Royal College of Physicians of Ireland Royal College of Surgeons in Ireland Royal Victoria Eye and Ear Hospital Research Foundation Ltd St John of God's Research Foundation Limited St. James's Hospital Teagasc The Alzheimer Society of Ireland The Children's Medical and Research Foundation Trinity College Dublin University College Cork University College Dublin University of California San Francisco University of Limerick University of Oxford
Funding Awarded
11 awards
Reducing caesarean section rates in Ireland: a feasibility study and pilot randomised trial of an evidence-based intervention designed to reduce unnecessary caesarean section
Concern has been expressed globally at the rising caesarean section (CS) rate with a lack of evidence of any associated decrease in health problems for mothers and babies, indicating that many CSs are unnecessary. Maternal death and severe maternal health problems are trebled following CS compared with vaginal birth, and newborn...
A randomised placebo-controlled trial of low-dose aspirin initiated in the first trimester for optimising pregnancy outcome in pregestational diabetes
Pre-existing diabetes confers a high risk for adverse pregnancy outcome. High blood pressure disorders in pregnancy, including preeclampsia, are particularly common in this population and the combination of pre-existing diabetes and preeclampsia represents a notable high risk for poor pregnancy outcome, including stillbirth....
Improving outcomes for young adults with type 1 diabetes in Ireland: the D1 now feasibility and cluster randomised pilot study
Many young adults with type 1 diabetes find it hard to control their blood glucose levels. With many changes going on in their lives their diabetes is often not a priority. They also find it hard to engage with hospital diabetes services because of an inflexible clinic appointment system and seeing a different member of staff at each...
The SEA-CHANGE study: a pilot randomised controlled trial of the SElf-management After Cancer of the Head And Neck Group intErvention
Head and neck cancer (HNC) and its treatment are associated with specific challenges such as facial disfigurement and impairments in speech, breathing and swallowing, which can have a negative impact on wellbeing. Despite these burdens, there is a lack of psychosocial interventions to help HNC survivors live well with and beyond...
We Can Quit2: A cluster randomised pilot trial of a community-based smoking cessation intervention for women in disadvantaged areas of Ireland
Smoking rates remain high in Ireland despite considerable progress being made to reduce them in recent years. Ireland ranks second highest for smoking-related causes of death in the EU. Lung cancer, which is strongly linked to smoking, is now the most common cause of death for women in Ireland particularly those living in more...
Colchine for prevention of vascular inflammation in non-cardioembolic stroke (CONVINCE) - a randomised clinical trial of low-dose colchicine for secondary prevention of stroke. Northern Europe extension
Inflammation of the lining of arteries is an important factor contributing to clots, leading to heart attacks and strokes. Current studies are testing medicines traditionally used for inflammation of joints (arthritis) to prevent strokes and heart attacks. CONVINCE is a clinical trial, testing colchicine in low doses, a medicine used...
Feasibility of an intervention to improve attendance for diabetic retinopathy screening
Retinopathy is a serious and common condition affecting the sight of people with diabetes and it can cause blindness. It is preventable through screening and can be treated if found in time. However, the success of screening is dependent on people attending when invited. Studies show that a number of people with diabetes do not attend...
Low molecular weight heparin to prevent recurrent venous thromboembolism in pregnancy: a randomised trial of two doses: the HIGHLOW study
Women who are pregnant have an increased chance of developing blood clots. These clots can cause serious ill-health and can even be fatal. The death of a young mother is a tragic event with wide-reaching effects on the woman's family.
Women with a previous blood clot have a higher recurrence risk in pregnancy. In fact, the...Targeted therapeutic mild hypercapnia after resuscitated cardiac arrest: A phase III multi-centre randomised controlled trial
A cardiac arrest occurs when the heart stops pumping blood to the brain and other major organs. Approximately 10,000 people die from cardiovascular disease every year in Ireland. It is estimated that 5,000 of these deaths are from a sudden cardiac arrest. Early resuscitation (CPR) can get the heart pumping again but in many cases the...
Community Risk-based monitoring for Atrial Fibrillation Trial (CRAFT)
Atrial fibrillation, an irregular heart-beat, is common, affecting ~7% of people over 65 years of age. It is a major cause of stroke, increasing the risk of stroke 5-fold, and about one-third of patients with acute stroke have atrial fibrillation. Once detected, there are very effective treatments to prevent stroke - oral anticoagulant...
Role of TWEAK/Fn14 pathway in mediating muscle pathology in SMA
Spinal muscular atrophy (SMA) is a devastating disease caused by loss of both nerve cells and muscle function. While the nerve is the major affected cell type, therapies specifically aimed at improving muscle function ameliorate survival and/or symptoms in SMA models. Thus,developing muscle-